Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HC.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.93 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.31.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BW.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.312NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.220NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.142NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.523NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.36.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.389NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.53NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.363NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.405NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.282NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.88 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.106 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.346NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.93NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BR.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBDNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EB.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CN.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.576NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.325NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.521NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.378NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.206NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used